Oyato Befekadu Tesfaye, Abasimel Husen Zakir, Tufa Derara Girma, Gesisa Hana Israel, Hussein Dursa, Chuko Bacha Merga
Department of Midwifery, College of Health Sciences, Salale University, Fitche, Ethiopia.
Department of Public Health, College of Health Sciences, Salale University, Fitche, Ethiopia.
Contracept Reprod Med. 2024 Dec 2;9(1):65. doi: 10.1186/s40834-024-00321-8.
Contraceptive discontinuation has become a widespread issue on a global basis. Implants, of which Implanon is the most popular, are only the second most widely used form of modern contraceptive in Ethiopia. However, Implanon was discontinued at a rate as high as 23.4% in Ethiopia within the first year of use. Therefore, the purpose of this study was to identify the incidence rate and predictors of unplanned discontinuation of Implanon in the first year of application at public hospitals in the North Shoa zone, Central Ethiopia.
A retrospective follow-up study was conducted at public hospitals in the North Shoa zone among women who use Implanon. A total of 429 women who wanted their Implanon removed after insertion were selected as study participants during the data collection period. Data were gathered from the family planning initiation and removal registration books as well as by contacting users directly. A log-rank test was used to assess the significance of observed differences between categorical variable strata. The acceleration failure time model with log-normal distribution was used to fit the survival data.
The unplanned discontinuation rate Implanon in the first year of insertion was 19.1% with an estimated mean survival time of 10.9 months (95% CI: 10.65, 11.14). Women with an interval period of insertion (AAF = 1.53; 95% CI: 1.06, 2.21), women who chose implanon by themselves (AFF = 1.32; 95% CI: 1.02, 1.71), women who were satisfied with the service (AFF = 1.40; 95% CI: 1.06, 1.83), and women who were given instructions on what to do if they experienced side effects (AFF = 1.85; 95% CI: 1.40, 2.44), had a lower likelihood of discontinuing their implanon in the first year of insertion.
The risk of unplanned Implanon discontinuation was found to be high in the study area. Health care providers should pay close attention to clients' needs when delivering family planning services, and the client should ultimately decide whether to use the service. Family planning departments must also engage in early-side effects treatment and reassure clients to lessen discontinuation.
避孕措施的停用已成为一个全球性的普遍问题。皮下埋植剂中,依伴侬最为常用,但在埃塞俄比亚,它只是第二大广泛使用的现代避孕方式。然而,在埃塞俄比亚,依伴侬在使用的第一年停用率高达23.4%。因此,本研究的目的是确定埃塞俄比亚中部北绍阿地区公立医院中,依伴侬在应用第一年意外停用的发生率及预测因素。
在北绍阿地区的公立医院对使用依伴侬的女性进行回顾性随访研究。在数据收集期间,共选取429名在植入依伴侬后要求取出的女性作为研究参与者。数据从计划生育起始和取出登记册收集,并直接联系使用者。采用对数秩检验评估分类变量各层间观察到的差异的显著性。使用对数正态分布的加速失效时间模型来拟合生存数据。
依伴侬在植入后的第一年意外停用率为19.1%,估计平均生存时间为10.9个月(95%置信区间:10.65,11.14)。植入间隔期较长的女性(AAF = 1.53;95%置信区间:1.06,2.21)、自行选择依伴侬的女性(AFF = 1.32;95%置信区间:1.02,1.71)、对服务满意的女性(AFF = 1.40;95%置信区间:1.06,1.83)以及接受过副作用应对指导的女性(AFF = 1.85;95%置信区间:1.40,2.44),在植入依伴侬的第一年停用的可能性较低。
研究区域内依伴侬意外停用的风险较高。医疗服务提供者在提供计划生育服务时应密切关注客户需求,最终应由客户决定是否使用该服务。计划生育部门还必须尽早进行副作用治疗并安抚客户,以减少停用情况。